Immunogenicity, Efficacy, and Safety of High-Dose Trivalent vs. MF59-Adjuvanted Trivalent vs. Standard-Dose Non-Adjuvanted Quadrivalent Influenza Vaccine in Solid Organ Transplant Recipients: A Randomised Clinical Trial. The STOP-FLU Trial | Publicación